PALATINE, Ill., May 1, 2009 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NasdaqCM:ACUR - News) (the ``Company'') today reported a first quarter 2009 net loss of $1.3 million or $0.03 per share compared to net income of $7.5 million, or $0.15 per diluted share for the first quarter of 2008. As of April 29, 2009, we had cash and cash equivalents of approximately $36.5 million with no term indebtedness.
